SALT OF DIAMINOPYRIMIDINE COMPOUNDS, AND SOLID FORM THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF

CRYSTAL FORM OF QUINOLINE COMPOUND AND PROCESS FOR ITS PRODUCTION

Siremadlin Succinate

Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid

METHODS OF TREATING NEUROCOGNITIVE DISORDERS, CHRONIC PAIN AND REDUCING INFLAMMATION

CRYSTAL FORM OF GONADOTROPIN RELEASING HORMONE ANTAGONIST, PREPARATION METHOD THEREFOR, AND USE THEREOF

6-pyrimidin-isoindole derivative as ERK1/2 inhibitor

SOLID FORMS OF ENCEQUIDAR MESYLATE AND PROCESSES THEREOF

Plinabulin compositions

CRYSTAL FORM OF DAPRODUSTAT, PREPARATION METHOD THEREFOR AND USE THEREOF

AMORPHOUS AND CRYSTALLINE FORMS OF IDO INHIBITORS

CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM

NOVEL SALTS, CRYSTALLINE FORMS AND PREMIX OF HYPOLIPIDEMIC AGENT

SALTS OF A COMPOUND, CRYSTAL FORMS OF THE SALTS AND PREPARATION METHOD AND USE THEREOF

Zinc oxide complexes

Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Polymorphs of a kinase inhibitor, pharmaceutical compositions containing such a compound, preparation methods, and applications

Solid state forms of substituted pyrazolopyrimidines and uses thereof

CRYSTALLINE POLYMORPHS OF A 1-THIAZOL-2-YL-PYRAZOLE-5-CARBOXYLIC ACID DERIVATIVE

Solid forms of an HPK1 inhibitor

CRYSTALLINE AND AMORPHOUS FORMS OF N-(5-((4-ETHYLPIPERAZIN-1-YL)METHYL)PYRIDINE-2-YL)-5-FLUORO-4-(3-ISOPROPYL-2-METHYL-2H-INDAZOL-5-YL)PYRIMIDIN-2-AMINE AND ITS SALTS, AND PREPARATION METHODS AND THERAPEUTIC USES THEREOF

CRYSTALLINE FORMS OF NEUROTROPHIN MIMETIC COMPOUNDS AND THEIR SALTS

CRYSTALLINE FORMS OF 4-(7-HYDROXY-2-ISOPROPYL-4-OXO-4H-QUINAZOLIN-3-YL)-BENZONITRILE AND FORMULATIONS THEREOF

Crystalline solid forms of salts of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use

SALT FORMS OF S-(N, N-DIETHYLCARBAMOYL)GLUTATHIONE

A CRYSTALLINE POTASSIUM SALT OF 2-O-ALPHA-D-GLUCOSYL-LASCORBIC ACID AND METHOD FOR PRODUCING THE SAME

Pharmaceutical crystal of contezolid acefosamil, preparation method therefor, and uses thereof

METHODS OF TREATING PARKINSON'S DISEASE

Process for preparing organotin compounds

SALTS OF 5,6-DIHYDRO-4H-THIENO[2,3-C]PYRROL-4-ONE COMPOUND AS ERK INHIBITORS

SOLID STATE FORMS OF ACALABRUTINIB

Salts of an FGFR inhibitor

Crystal of heterocyclic amide compound and method for producing same

Pharmaceutical formulations of -(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylaminde and salts thereof

SYNTHESIS OF STABLE AMORPHOUS APALUTAMIDE

Crystal form of tetramethylpyrazine nitrone, preparation method and use thereof

CRYSTAL FORM E OF BULLEYACONITINE A, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

THERMOPLASTIC RESIN, METHOD FOR MANUFACTURING SAME, AND OPTICAL LENS

COMPOUNDS AND METHODS FOR MANUFACTURE OF HYPOMETHYLATING AGENTS

Crystalline form of Remdesivir

Polymorphs of integrase inhibitor

Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof

Crystalline form of a PD-1/PD-L1 inhibitor

Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof

PROCESS FOR PREPARATION OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE

METHOD FOR OBTAINING FUCOXANTHIN AND FATTY ACIDS FROM THE BIOMASS OF ALGAE

MONO-(ACID) SALTS OF 6-AMINOISOQUINOLINES AND USES THEREOF

SOLID STATE FORMS OF SIPONIMOD

Crystalline form of 3-((L-valyl) amino))-3, 3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof

UREA DERIVATIVE

PROCESS FOR PREPARATION OF MIDODRINE AND INTERMEDIATES THEREOF

Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid

Nitrile-containing antiviral compounds

Preparation and application of a 5-bromoquinazoline derivative

Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same

CRYSTALLINE SOLID FORMS OF BARICITINIB

Crystalline forms of a deoxycytidine kinase inhibitor and uses thereof

SOLID STATE FORMS OF N-[2-(2-{4-[2-(6,7-DIMETHOXY-3,4-DIHYDRO-2(1H)-ISOQUINOLINYL)ETHYL]PHENYL}-2H-TETRAZOL-5-YL)-4,5- DIMETHOXYPHENYL]-4-OXO-4H-CHROMENE-2-CARBOXAMIDE AND OF ITS MESYLATE SALT

Polymorphs of Selinexor

Crystalline forms of piperazine-1,4-diylbis((6-(1H-benzo[d]imidazo-2-yl)pyridin-2yl)methanone)

PROCESS FOR SYNTHESIZING 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDE

Crystalline PPARδ agonist

PROCESSES FOR PREPARING ASK1 INHIBITORS

Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrate

Treprostinil monohydrate crystals and methods for preparation thereof

POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN

Manufacturing process and intermediates for a pyrrolo[2,3-d]pyrimidine compound and use thereof

Salt of aldose reductase inhibitor, and preparation method and application thereof

Processes for the preparation of 4-{8-amino-3-[(2S)-1-(but-2-ynoyl)-pyrrolidin-2-yl]imidazo[1,5-a]-pyrazin-1-yl}N-(pyridin-2-yl)-benzamide

Solid state forms of lumateperone ditosylate salt

CRYSTALLINE FORM OF A CDK INHIBITOR

SOLID STATE FORMS OF VALBENAZINE

Crystalline form of 1-(1-oxo-1,2-dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1H-pyrazole-4-carboxamide monohydrate

Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

Crystalline form of ivacaftor and a process for preparing the same

CRYSTAL COMPOSITION (CC) COMPRISING 4,4'-DICHLORODIPHENYLSULFOXIDE CRYSTALS (C)

Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate

Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate

PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN

POLYMORPHOUS FORMS OF RIFAXIMIN, PROCESSES FOR THEIR PRODUCTION AND USE THEREOF IN THE MEDICINAL PREPARATIONS

Crystalline forms of Mnk inhibitors

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

N-long chain acyl lysine crystal production method and composition containing said crystals

Ketamine pamoate and use thereof

DIARYL MACROCYCLES AS MODULATORS OF PROTEIN KINASES

Crystalline polymorphs of sodium (4R,12AS)-9-{[(2,4-difluorophenyl) methyl]carbamoyl}-4-methyl-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido [1′,2′:4,5]pyrazino[2,1-b][1,3]oxazin-7-olate and process for preparation thereof

Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor

CRYSTALLINE FORMS OF A BRUTONS TYROSINE KINASE INHIBITOR

CRYSTALLINE FORMS OF AN RSK INHIBITOR

INHIBITORS OF ROR GAMMA

Process of reworking a crystalline form of a glycine transport inhibitor

Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

SOLID FORMS OF A PROMOTER OF SPINOGENESIS

CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF

Solid state forms

Method and system for extracting long chain dicarboxylic acid

2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders

Fospropofol salts, methods and compositions

STABLE SOLID DISPERSION OF A B-RAF KINASE DIMER INHIBITOR, METHODS OF PREPARATION, AND USES THEREFOR

strains and their metabolites to control plant diseases

γ-aminobutyric acid modulator crystal form X, preparation method and application thereof

CRYSTAL FORMS OF BETA-NICOTINAMIDE MONONUCLEOTIDE

Solid state forms of oclacitinib maleate

THE MONOHYDRATE OF ROGARATINIB HYDROCHLORIDE AND SOLID STATES THEREOF

Synthetic co-crystals of anhydrous guanine and process for preparing the same

SALTS OF HETEROCYCLIC COMPOUND AND USE THEREOF

Process for the preparation of trametinib acetic acid solvate

POLYMORPHIC FORMS OF A SUBSTITUTED-QUINOXALINE-TYPE BRIDGED-PIPERIDINE COMPOUND

Crystalline form of tegavivint, method of preparation, and use thereof

CRYSTALS OF QUINOLONE DERIVATIVES

Nicotine salts, co-crystals, and salt co-crystal complexes

SALTS OF A HETEROCYCLIC COMPOUND AND CRYSTALLINE FORMS, PROCESSES FOR PREPARING, THERAPEUTIC USES, AND PHARMACEUTICAL COMPOSITIONS THEREOF

Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamide

Novel Crystalline Forms

FREE BASE CRYSTALLINE FORM OF A COMPLEMENT COMPONENT C5a RECEPTOR

CRYSTALLINE FORMS OF DEXAMETHASONE DIMERS AND USES THEREOF

Solid forms of TTK inhibitor

ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE STATES AND CONDITIONS

Polymorphs of an SSAO inhibitor

High-purity thermostable crystal form of substituted 3-isoxazolidinone compound, preparation method therefor and application thereof

CRYSTALLINE FORMS OF (S)-2-(7-CYANO-1H-BENZIMIDAZOL-1 YL)-N-{1-[4-(1-CYANO-1-METHYLETHYL)PHENYL]ETHYL}ACETAMIDE

Synthesis Method for Candesartan Cilexetil Intermediate

Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

Compounds and methods for treatment of viral infections

CRYSTAL FORM OF 1,2,3-TRIAZOLO[1,5-A]PYRAZINES DERIVATIVE AND PREPARATION METHOD FOR CRYSTAL FORM

POLYMORPHIC FORM OF SEPIAPTERIN

SOLID FORMS OF A COMPOUND FOR MODULATING KINASES

Crystalline and amorphous forms of a compound for the targeted degradation of estrogen receptor

Process for Preparation of Imidacloprid Polymorph Form I

Integrin antagonists

Crumbly phase composition of methylglycine N,N diacetic acid

2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

IL-17A inhibitors

CRYSTALLINE SPIROCYCLIC COMPOUND, A DOSAGE FORM CONTAINING, A METHOD FOR USING IN TREATMENT OF DISEASE, AND A METHOD FOR RECRYSTALLIZING

Crystal of pyrrolidine compound

KDM1A inhibitors for the treatment of disease

Crystalline form of propoxazepam, the method of its making and use as medicinal agent

Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof

Formulations of T-type calcium channel modulators and methods of use thereof

CRYSTAL FORMS OF AMINO LIPIDS

AMORPHOUS FORM OF 5-BROMOPYRIDIN-3-YL 3-DEOXY-3-[4-(3,4,5-TRIFLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YL]-1-THIO-ALPHA-D-GALACTOPYRANOSIDE

Crystalline forms of a PAR4 inhibitor

Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof

1,2,4-oxadiazole derivatives as liver X receptor agonists

Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases

SOLID STATE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODULATOR

METHOD FOR PRODUCING 1,2-ALKANE DIOLS IN A SOLID DOSAGE FORM

Crystalline forms and processes of lenvatinib besylate

Nitrile-containing antiviral compounds

De novo design of potent and selective interleukin mimetics

Crystalline forms of an NRTTI compound

Solid forms of ceftolozane and processes for preparing

Process and intermediates for preparing a JAK inhibitor

Crystalline forms of a selective c-kit kinase inhibitor

AMORPHOUS FORM OF A MALT1 INHIBITOR AND FORMULATIONS THEREOF

Crystalline forms of a quinazoline compound and its hydrochloride salts

CRYSTALLINE FUMARATE SALT OF (S)-[3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)PHENYL] [3-HYDROXY-3-(PIPERIDIN-2-YL) AZETIDIN-1-YL]-METHANONE

Crystalline and salt forms of an organic compound and pharmaceutical compositions thereof

NOVEL CRYSTALLINE FORMS OF SUGAMMADEX

PKC INHIBITOR SOLID STATE FORMS

Co-crystals, method and apparatus for forming the same

Methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate active compound product having improved properties, production and formulation thereof

Method of manufacturing a solid form of a BET bromodomain inhibitor

Crystalline forms of 3-substituted 1,2,4-oxadiazole

Crystalline form of 4-amino-n-tert-butyl-4,5-dihydro-3-isopropyl-5-oxo-1,2,4-1H-triazole-1-carboxamide and a process for producing thereof

Method for preparing brivaracetam and intermediate thereof

Polymorphic forms of RAD1901-2HCL

Treprostinil salt

Crystalline form of Di-p-toluoyl-L-tartrate of upadacitinib

Solid forms of N-(4-fluoro-3-(6-(3-methylpyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)phenyl)-2,4-dimethyloxazole-5-carboxamide

RIBOCICLIB SALTS AND SOLID STATE FORMS THEREOF

Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3- yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use

Polymorphs of N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide and salts thereof

(3aS,4aR,5S,7aS,9R,9aR)-2,2,5,8,8,9a-hexamethyloctahydro-4H-4a,9-methanoazuleno[5,6-d][1,3]dioxole

Processes for preparing AG-10, its intermediates, and salts thereof

Aramchol salts

Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

Solid form, crystalline form, and crystal form a of FXR agonist, and preparation method and application thereof

Enantiomerically purified GPER agonist for use in treating disease states and conditions

CRYSTAL FORM A OF 2-(2, 5-DIOXOPYRROLIDIN-1YL) ETHYL METHYL FUMARATE, PREPARATION METHOD THEREFOR AND USE THEREOF

Crystalline form a of 2, 2-bis(4-fluorophenyl)-2-phenylacetamide and preparation method therefor and application thereof

Lyophilisate of treosulfan

COMPOUNDS WITH HIV MATURATION INHIBITORY ACTIVITY

SALTS AND CRYSTAL FORMS OF GABA-A POSITIVE ALLOSTERIC MODULATOR

Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

Salts and processes of preparing a PI3K inhibitor

3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator

SOLID STATE FORMS OF LUMATEPERONE SALTS AND PROCESSES FOR PREPARATION OF LUMATEPERONE AND SALTS THEREOF

Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide

Processes and intermediates for the preparation of soluble guanylate cyclase stimulators

CRYSTALLINE FORM OF PROPANAMIDE DERIVATIVE AND PREPARATION METHOD THEREFOR

Polymorophs of 5-aza-4′-thio-2′-deoxycytidine

Crystalline forms of 1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]pyrazole-4-carboxamide

CRYSTALLINE FORMS OF 1-(1,2-DIMETHYLPROPYL)-N-ETHYL-5-METHYL-N-PYRIDAZIN-4-YL-PYRAZOLE-4-CARBOXAMIDE

2-(2,4,5-SUBSTITUTED PHENYLAMINO) PYRIMIDINE DERIVATIVE AND CRYSTALLINE FORM B THEREOF

Crystalline forms of 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate

Crystalline forms of 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate

Crystalline forms of a compound for treating or preventing gout or hyperuricemia

Crystalline PPAR-delta agonist

Process route of compound of formula (IV), crystal form and preparation method therefor

Multi-component crystals of an orally available HIF prolyl hydroxylase inhibitor

CRYSTALLINE FORMS OF MULTICYCLIC COMPOUNDS AND USES THEREOF

Combinations for treatment of NASH/NAFLD and related diseases

Compounds and methods for the treatment of COVID-19

Crystal form of hepatitis B surface antigen inhibitor

Crystalline forms of a MCL-1 inhibitor, a process for their preparation and pharmaceutical compositions containing them

Crystal forms of crenolanib and methods of use thereof

Salt of Syk inhibitor and crystalline form thereof

CO-CRYSTALS OF 2-METHYL-1 -[(4-[6-(TRIFLUOROMETHYL)PYRIDIN-2-YL]-6-{[2-(TRIFLUOROMETHYL) PYRIDIN-4-YL]AMINO}-1,3,5-TRIAZIN-2-YL)AMINO]PROPAN-2-OL, COMPOSITIONS AND METHODS OF USE THEREOF

SOLID DISPERSIONS FOR TREATMENT OF CANCER

Polymorphic compounds and uses thereof

Form of isoquinoline sulfonamide

Formulations of T-type calcium channel modulators and methods of use thereof

Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method therefor

Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid

Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

POLYMORPHIC FORMS OF IBRUTINIB

CRYSTAL OF DIARYLTHIOHYDANTOIN COMPOUND

Solid state forms of Reproxalap

Crystalline freebase forms of a biphenyl compound

POLYMORPHIC FORM OF MEISOINDIGO AND MODIFIED FORMULATION OF MEISOINDIGO

CRYSTALLINE SOLVATE FORMS OF A PHARMACEUTICAL

CRYSTALLINE FORM A OF 2'-FLUORO-4'-SUBSTITUTED NUCLEOSIDE ANALOGUE I AND PREPARATION METHOD AND APPLICATION THEREOF

Process for preparing organotin compounds

Salt and crystalline form of furopyrimidine compound and pharmaceutical use thereof

CRYSTAL FORM OF UPADACITINIB AND PREPARATION METHOD AND USE THEREOF

NOVEL POLYMORPHS OF ACALABRUTINIB, A BRUTON'S TYROSINE KINASE INHIBITOR

Aminopyrimidinyl derivatives

POLYMORPHS OF X842

CRYSTALLINE FORMS OF A SUBSTITUTED IMIDAZOPYRIDINE COMPOUND AND USE THEREOF AS P2X3 MODULATOR

MELOXICAM CO-CRYSTALS

PYRIDONE DERIVATIVE HAVING TETRAHYDROPYRANYLMETHYL GROUP

Crystalline form of N-butyldeoxygalactonojirimycin

Crystalline L-arginine salt of ()-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1Preceptor-associated disorders

A CRYSTALLINE FORM OF 3- ((L-VALYL) AMINO) -1-PROPANESULFONIC ACID

Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity

CRYSTALLINE FORMS OF METYROSINE

Forms of pyrido[1,2-a]pyrimidin-4-one derivatives, its formulation and its process of making

Folate salts

Crystalline forms of deuterium-enriched pioglitazone

Solid forms of 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl) amino]propan-2-ol

Crystal form a of NHE3 inhibitor, preparation method therefor and application thereof

Niraparib compositions

Process for the preparation of N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide, (2S)-hydroxybutanedioate and its polymorphs thereof

Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

PREPARATION AND USES OF OBETICHOLIC ACID

Crystalline forms of a CD73 inhibitor and uses thereof

Crystalline forms of IRAK degraders

Methyl (r)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1H-cyclopenta[b]pyridine-3-carboxylate and methyl (r)-2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-b]pyridine-3-carboxylate as CAV1.2 activators

NOVEL CRYSTAL OF (3S)-3-[2-(6-AMINO-2-FLUOROPYRIDIN-3-YL)-4-FLUORO-1H-IMIDAZOL-5-YL]-7-[5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL]-2,3-DIHYDROINDOLIZIN-5(1H)-ONE

BTK INHIBITORS, PHARMACEUTICALLY ACCEPTABLE SALTS, POLYMORPHS AND APPLICATION THEREOF

CO-CRYSTAL FORMS OF SELINEXOR

Crystalline forms of potassium channel modulators

NICOTINE SALTS, CO-CRYSTALS, AND SALT CO-CRYSTAL COMPLEXES

3-(1,2,3,6-tetrahydropyridin-2-YL) pyridine glutarate or a pharmaceutically acceptable solvate thereof

LOW HYGROSCOPIC ARIPIPRAZOLE DRUG SUBSTANCE AND PROCESSES FOR THE PREPARATION THEREOF

POLYMORPHIC FORMS OF A COMPOUND AND USES THEREOF

Crystalline form of sofpironium bromide and preparation method thereof

Crystalline polymorphs of Rigosertib Sodium

Co-crystals comprising levothyroxine and a dicarboxylic acid

Pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using same

SPECIFICALLY-SHAPED CRYSTAL OF COMPOUND AND METHOD FOR PRODUCING SAME

Solid state forms of voclosporin

Method for obtaining crystalline 2′-fucosyllactose

Radio-protective and chemo-protective substituted thiols

ORGANIC METAL-HALIDE PEROVSKITE PRECURSOR, PROCESS FOR PRODUCTION AND USE THEREOF

Crystalline forms of lorlatinib maleate

Morphic forms of trilaciclib and methods of manufacture thereof

POLYMORPH FORM OF A MONOPHOSPHATE HYDRATE SALT OF A KNOWN TETRAHYDROISOQUINOLINE DERIVATIVE

Pyrrolo[2,3-d]pyrimidine tosylate salt, crystalline form thereof and manufacturing process and intermediates thereto

Hemi (L)-tartrate forms of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1-indol-2-yl}methyl)-1-(2,2,2-trifluoroethy)-1,3-dihydro-2-imidazo[4,5-C]pyridin-2-one and pharmaceutical compositions comprising the same

CRYSTALLINE ALK5 INHIBITORS AND USES THEREOF

Process for the preparation of Rivaroxaban involving novel intermediate

Crystalline polymorphs of Bruton's tyrosine kinase inhibitors

2-heteroaryl aminoquinazolinone derivative

PROCESS FOR PREPARING CARYOPHYLLENE OXIDE

SOLID STATE FORMS OF DAPRODUSTAT AND PROCESS FOR PREPARATION THEREOF

Acetylsalicylic acid derivative and application thereof

SOLID DISPERSIONS AND PHARMACEUTICAL COMPOSITIONS COMPRISING A SUBSTITUTED INDANE AND METHODS FOR THE PREPARATION AND USE THEREOF

Crystalline form of treosulfan

Solid forms of thiophene derivatives

UPADACITINIB CRYSTAL FORM AND PREPARATION METHOD THEREFOR AND USE THEREOF

2-INDOLYL IMIDAZO[4,5-D]PHENANTHROLINE POLYMORPHS AND COMPOSITIONS REGARDING THE SAME

Crystalline forms and processes for the preparation of cannabinoid receptor modulators

Crystalline form of nilotinib hydrochloride, process for its preparation and pharmaceutical composition containing the same

Salt and solid state forms of escitalopram

Crystal forms of immunomodulators

Solid state forms of Pemafibrate

NOVEL PROCESS FOR THE PREPARATION OF MACROCYCLIC CHELANT 2,2',2''-(10-(2-HYDROXYPROPYL)-1,4,7,10-TETRA AZACYCLODODECANE-1,4,7-TRIYL) TRIACETIC ACID AND IT'S COMPLEXES WITH PARAMAGNETIC METAL IONS

CO-CRYSTALS COMPRISING EPICATECHIN AND A CARBOXY-N-HETEROCYCLIC CO-CRYSTAL FORMER

Solid compositions of cocrystals of cannabinoids

Cyclic-di-AMP sodium salt crystal

Process for preparing Alectinib or a pharmaceutically acceptable salt thereof

CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE

TrkA Inhibitor

Crystalline form of LNP023